Affordable Access

deepdyve-link
Publisher Website

Nodular regenerative hyperplasia (NRH) complicating oxaliplatin chemotherapy in patients undergoing resection of colorectal liver metastases.

Authors
  • Morris-Stiff, G1
  • White, A D1
  • Gomez, D2
  • Cameron, I C2
  • Farid, S1
  • Toogood, G J1
  • Lodge, J P A1
  • Prasad, K R3
  • 1 Department of Hepatobiliary and Transplant Surgery, St James' University Hospital, Leeds LS9 7TF, UK.
  • 2 Department of Hepatobiliary and Pancreatic Surgery, Queen's Medical Centre, Derby Road, Nottingham NG7 2UH, UK.
  • 3 Department of Hepatobiliary and Transplant Surgery, St James' University Hospital, Leeds LS9 7TF, UK. Electronic address: [email protected]
Type
Published Article
Journal
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Publication Date
Aug 01, 2014
Volume
40
Issue
8
Pages
1016–1020
Identifiers
DOI: 10.1016/j.ejso.2013.09.015
PMID: 24370284
Source
Medline
Keywords
License
Unknown

Abstract

NRH is not an uncommon finding amongst patients with SOS with all patients having received oxaliplatin-based chemotherapy. Data on outcome would suggest no increased morbidity and mortality associated with the presence of NRH.

Report this publication

Statistics

Seen <100 times